Trial Profile
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate 0.05% and 0.015% Gel Followed by Hand Washing in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Apr 2011
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Adverse reactions
- 27 Mar 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 27 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.